Funds and ETFs Harbin Pharmaceutical Group Co., Ltd.

Equities

600664

CNE0000009T3

Pharmaceuticals

End-of-day quote Shanghai S.E. 18:00:00 2024-04-29 EDT 5-day change 1st Jan Change
3.1 CNY +2.99% Intraday chart for Harbin Pharmaceutical Group Co., Ltd. +11.91% -7.46%

ETFs positioned on Harbin Pharmaceutical Group Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +2.04% -
Harbin Pharmaceutical Group Co is a China-based company mainly engaged in pharmaceutical research and development. The Company's main businesses are innovative research and development in high-tech fields such as antibiotics, modern Chinese medicine, and biopharmaceuticals, covering the business sectors of antibiotics, over-the-counter drugs and health products, traditional and modern Chinese medicine, biomedicine, and pharmaceutical commerce. The Company’s main products include calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsules, Shuanghuanglian oral solution, alprostadil injection, pediatric paracetamol Huangnamin granules, lacidipine tablets, hydrochloric acid for injection Cefotiam, ibuprofen granules, Xingaizhonggai high calcium tablets, etc.
More about the company
  1. Stock Market
  2. Equities
  3. 600664 Stock
  4. Funds and ETFs Harbin Pharmaceutical Group Co., Ltd.